Mainz Biomed N.V. (MYNZ)
NASDAQ: MYNZ · Real-Time Price · USD
1.890
-0.110 (-5.50%)
At close: Jul 11, 2025, 4:00 PM
1.940
+0.050 (2.65%)
After-hours: Jul 11, 2025, 6:59 PM EDT
Mainz Biomed Market Cap
Mainz Biomed has a market cap or net worth of $6.60 million as of July 11, 2025. Its market cap has decreased by -19.53% in one year.
Market Cap
6.60M
Enterprise Value
3.64M
1-Year Change
-19.53%
Ranking
Category
Stock Price
$1.89
Market Cap Chart
Since the IPO on November 5, 2021, Mainz Biomed's market cap has decreased from $58.55M to $6.60M, a decrease of -88.72%. That is a compound annual growth rate of -44.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 6.60M | -54.62% |
| Dec 31, 2024 | 14.55M | -38.37% |
| Dec 29, 2023 | 23.62M | -77.05% |
| Dec 30, 2022 | 102.90M | -17.54% |
| Dec 31, 2021 | 124.78M | 113.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 709.79B |
| Johnson & Johnson | 379.41B |
| AbbVie | 344.45B |
| Novo Nordisk | 316.64B |
| UnitedHealth Group | 271.70B |
| Novartis AG | 243.81B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 223.49B |